查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1837179

血管假體市場按產品類型、血管直徑、適應症、最終用戶和分銷管道分類 - 全球預測 2025-2032

Vascular Graft Market by Product Type, Blood Vessel Diameter, Indication, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年血管移植市場規模將成長至 41.3 億美元，複合年成長率為 7.58%。

主要市場統計數據
基準年2024年 23億美元
預計2025年 24.7億美元
預測年份：2032年 41.3億美元
複合年成長率（%） 7.58%

一個簡潔的技術框架，涵蓋臨床、技術和商業性要求，將塑造下一個時代的血管移植利用和策略

血管移植領域正處於關鍵的曲折點源於臨床需求、材料創新和不斷發展的醫療服務模式的整合。血管移植用於修復或取代受損血管，涵蓋從心血管外科到周邊介入等各個學科，隨著人口結構變化導致血管疾病盛行率上升，其重要性也不斷提升。生物材料和製造技術的進步正在拓展臨床醫生的選擇，而手術全期護理和診斷影像技術的改進正在重塑手術決策。因此，醫療服務提供者和採購團隊必須協調臨床績效需求與營運限制和報銷動態。

在此背景下，相關人員需要清晰的、基於臨床的產品屬性、用例差異化、監管途徑和分銷考慮。本引言透過闡述推動植入物選擇的臨床必要性、創造差異化的技術槓桿以及影響應用的商業性機制，為後續分析奠定了基礎。透過將臨床效用與策略選擇連結起來，本節為產品開發、供應鏈最佳化和臨床應用途徑的實際決策奠定了基礎。執行摘要的其餘部分將從基礎理解轉向策略考量，探討結構性變化、關稅影響、細分特性、區域動態、競爭定位、建議行動、研究途徑以及結論性要點。

臨床進展、材料創新和分銷現代化如何重塑整個血管假體生態系統的競爭動態

血管假體生態系統正在經歷一場變革性的轉變，這得益於材料科學的突破、臨床通訊協定的不斷變化以及醫療服務從集中式轉向門診/門診的轉變。生物製藥和合成聚合物的創新使得移植物能夠更好地模擬原生血流動力學並降低血栓形成風險，而混合結構和表面修飾則正在擴大其可行適應症的範圍。同時，手術路徑也在不斷發展：微創手術和混合手術室日益普及，改變了手術全期工作流程和器械組裝要求。

同時，監管審查和品質標準日益嚴格，迫使製造商投資於強力的證據生成和上市後監管。隨著相關人員優先考慮多種籌資策略並深化與經銷商的夥伴關係關係，供應鏈的彈性和分銷的敏捷性日益受到關注。這些轉變，加上採購和臨床醫生教育的數位化加速，正在推動臨床數據和設備使用通訊協定的快速傳播。那些將研發重點與不斷變化的臨床醫生工作流程相結合，並投資於嚴格臨床檢驗的公司，將能夠抓住不斷擴展的臨床用例，並保持長期應用。

評估不斷變化的貿易措施和關稅動態如何重塑血管移植相關人員的採購決策、供應鏈彈性和籌資策略

由於關稅及相關貿易行動影響籌資策略和成本結構，政策和貿易措施為供應鏈計算和採購計劃引入了新的變數。關稅帶來的成本壓力正促使製造商和醫療保健系統重新評估其供應商佈局，考慮近岸外包和回流選項，並重新評估長期合約以降低風險。這些應對措施不僅涉及商業性層面，還會影響臨床營運，因為採購計劃和庫存政策需要進行調整，以確保醫療服務的連續性並維持優先移植類型的可及性。

醫療保健機構擴大進行總擁有成本分析，其中涵蓋關稅、物流變化和潛在延誤的影響。同時，製造商也在評估降低關稅的措施，例如關稅工程、替代路線、關鍵零件本地化以及與區域契約製造建立戰略夥伴關係。最終結果是分銷網路重組，並更加重視多層次應急計劃。隨著相關人員的適應，臨床負責人、採購團隊和供應鏈專業人員之間的協作對於平衡成本控制和臨床績效至關重要，並確保病患照護路徑不受地緣政治和政策波動的影響。

細緻的細分框架，將產品材料、尺寸、適應症、最終用戶環境和分銷管道與臨床應用和商業策略聯繫起來

細分產品類型、尺寸、適應症、最終用戶和分銷管道等因素，為理解不同的採用模式和臨床適用性提供了分析基礎。生物移植物（包括同種異體移植物、自體移植物和異質骨移植）具有固有的生物相容性優勢，但通常需要特殊的處理和供體來源的考慮。這些材料和處理的差異直接影響臨床醫生的偏好和庫存管理。

將血管直徑細分為大、小兩類可以進一步完善臨床決策，因為尺寸限制和流動動態會改變移植物選擇標準和手術技術。從主動脈和腦動脈繞道手術到冠狀動脈繞道術、下肢繞道手術、周邊動脈繞道手術和腎動脈繞道手術，以適應症為中心的細分強調手術環境對動態和解剖學的要求各不相同，這些要求會影響器械設計和證據要求。門診手術中心、醫院和診所之間的最終用戶差異凸顯了手術量、人員配備模式和採購能力方面的差異，這反過來又會影響首選的產品系列。最後，線上和線下的分銷管道細分決定了產品到達臨床醫生和購買者的方式。線下通路持續支援複雜器材的實務訓練和物流，而線上管道則促進資訊取得和批量採購。整合這些細分維度使相關人員能夠更精準地確定開發、臨床證據產生和商業策略，以滿足差異化的臨床和營運需求。

區域動態和醫療保健系統的細微差別決定了全球主要市場的採購偏好、臨床採用途徑和分銷策略

區域動態正在顯著影響整個血管移植領域的臨床實踐模式、監管格局和供應鏈架構。在美洲，醫療保健系統將先進的臨床基礎設施與複雜的報銷生態系統相結合，推動了對可靠、長期證據和高性能設備的需求，而大型獨立經銷商的存在則影響著通路策略和庫存實踐。在歐洲、中東和非洲，各國醫療保健系統各不相同，需要採取適應性的監管策略和彈性價格設定方法。在亞太地區，新興市場對成本敏感的採購和都市區快速擴張的臨床能力的雙重動態為高階和注重價值的產品供應創造了機會。

在全部區域，醫生培訓途徑、手術量以及住院和門診治療之間的平衡差異決定了特定植入物類型和技術的採用曲線。與製造地的接近性、區域貿易協定和物流基礎設施會影響前置作業時間和庫存管理。因此，尋求地理擴張的公司必須根據區域特點客製化其臨床參與、監管申報和分銷經銷夥伴，同時保持一致的品質和證據標準。與當地臨床領導者和營運合作夥伴的策略協調對於在不同地區的醫療保健系統中持續採用至關重要。

決定血管移植領域領導地位的關鍵競爭定位因素，重點在於臨床證據、製造能力、策略夥伴關係和商業化模式

血管移植領域的競爭優勢取決於臨床證據、材料創新、製造可靠性、合規性和管道實力的綜合考量。擁有完善製造和上市後監管能力的成熟製造商會利用其過往業績與大型醫院系統和學術中心合作，並通常會將產品系列與培訓和臨床支持項目相結合，以提升市場偏好。新興企業和新興企業則力求透過新型生物材料、表面工程方法和針對性適應症來實現差異化，在特定臨床場景中展現其臨床優勢和易用性。

器械開發商與契約製造以及特種塗層供應商之間的夥伴關係日益普遍，旨在加快臨床推廣速度並控制資本強度。分銷策略多種多樣，從大力支持的醫院內直銷，到透過第三方分銷商和電商平台定期補貨的混合模式。此外，與臨床研究網路和註冊平台建立策略聯盟，使公司能夠產生高品質的真實世界證據，以支持處方和臨床醫生的採用。最終，能夠有效協調研發重點、可擴展生產和差異化商業性模式的公司，最有能力應對報銷壓力和臨床醫生的期望，同時保護其長期收益來源。

製造商和醫療保健領導者的策略重點是加強血管移植臨床證據、提高供應彈性並確保及時商業化

產業領導者必須在臨床、營運和商業層面採取協調一致的行動，以實現長期價值。優先對目標適應症進行嚴格的臨床檢驗，可以增強報銷論點和臨床醫生的信心，尤其是在證據生成與註冊登記和上市後監測相結合，以證明其真實世界療效的情況下。同時，投資材料科學項目，無論是生物支架、混合結構或表面改質技術，都可以透過通暢性和降低併發症發生率來創造有意義的差異化。

在開發方面，實現製造地多元化並制定緊急採購計劃可以降低關稅和物流風險。與區域製造商合作還可以加快市場進入速度並縮短前置作業時間。商業性，認知到門診手術中心與醫院和診所之間的差異，並根據他們的需求量身訂做打入市場策略，可以提高採用率。對於複雜的手術，強化教育和實踐培訓至關重要；而對於大批量生產，精簡的採購和可重複的物流支援規模化。最後，利用數位管道與臨床醫生互動，並利用線上分銷進行常規補貨，可以補充傳統的銷售模式。透過實施這些綜合建議，組織可以提高韌性，增進臨床醫生的信任，並使其產品與不斷發展的醫療服務規範保持一致。

簡要描述用於綜合臨床、商業和供應鏈見解的資訊來源、相關人員諮詢和分析方法

本研究綜合基於對同行評審臨床文獻、監管和專利現狀、公開臨床登記冊以及與臨床醫生、供應鏈負責人和商業專家的相關人員訪談的系統回顧。主要定性資訊是透過結構化諮詢獲得的，旨在檢驗臨床偏好、設備操作注意事項和採購動態。二級資訊來源提供了有關材料科學趨勢、設備核准和程序指南的背景資訊，從而能夠跨證據流進行三角測量。

分析方法包括：根據不同適應症和直徑的臨床需求，比較評估器械屬性，評估分銷管道的有效性，並進行情境分析，以考慮關稅導致的供應鏈調整的影響。我們使用多個獨立資訊來源來支持索賠，並注意區分既定的臨床共識和新興假設。自始至終，我們專注於可操作的見解，而非原始的資料集列表，確保研究結果與產品策略、臨床參與和採購計劃直接相關。在適當的情況下，我們會指出研究的局限性以及需要進一步收集原始數據的領域，指南後續研究和證據生成。

策略整合強調臨床檢驗、材料創新和供應彈性的整合，作為血管移植技術永續應用的基礎

這些同步發展創造了一個複雜的環境，其中臨床表現、營運彈性和監管協調各自發揮關鍵作用。相關人員的成功需要整合策略，將嚴格的證據產生、製造適應性和客製化的商業性執行相結合。

展望未來，最具永續性的優勢將屬於那些能夠快速將科學進步轉化為檢驗的臨床效益、維護靈活且冗餘的供應鏈，並為臨床醫生提供有針對性的教育和營運支援的組織。如此一來，相關人員就能確保新移植技術的前景得以實現，成為改善病患預後、實現永續臨床應用的途徑。將技術創新與實際應用結合，是抓住新機會並保障醫療連續性的關鍵。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 內皮化生物工程小直徑血管移植物在冠狀動脈應用的進展
  • 可吸收聚合物複合移植物在兒科血管重建術的應用日益增多
  • 肝素塗層膨體聚四氟乙烯移植物在糖尿病患者保肢手術的應用日益增多
  • 3D列印患者專用血管移植的出現，可最佳化動脈瘤修復中的血流動力學性能
  • 增加對整合幹細胞接種的組織工程移植技術的投資，以提高長期通暢率
  • 報銷政策和價值導向護理模式的演變對新興市場血管移植應用的影響

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章血管假體市場（依產品類型）

  • 生物血管移植
    • 同種異體移植
    • 自體移植
    • 異種移植
  • 合成血管移植物
    • 聚酯纖維
    • 聚四氟乙烯
    • 聚氨酯

第9章 人造血管市場（依血管直徑）

  • 大的
  • 小的

第 10 章血管移植市場（按適應症）

  • 主髂動脈繞道手術
  • 腦動脈繞道手術
  • 冠狀動脈繞道術
  • 下肢搭橋手術
  • 周邊動脈繞道手術
  • 腎臟動脈繞道手術

第 11 章血管移植市場（依最終用戶）

  • 門診手術中心
  • 醫院和診所

第12章血管移植市場（依通路）

  • 離線
  • 線上

第13章 人工血管市場：依地區

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章血管假體市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 血管假體市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • Affluent Medical
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company
    • BIOVIC Sdn. Bhd.
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Cook Medical, Inc.
    • Corcym Srl
    • CryoLife, Inc.
    • Endologix Inc.
    • Getinge AB
    • Heart Medical Europe BV
    • Japan Lifeline Co., Ltd.
    • Lemaitre Vascular, Inc.
    • Medtronic PLC
    • Merit Medical Systems, Inc.
    • Perouse Medical SAS by Vygon SAS
    • Rua Life Sciences PLC
    • Shanghai Suokang Medical Implants Co. Ltd.
    • Terumo Corporation
    • Vascular Graft Solutions Ltd.
    • VUP Medical
    • WL Gore & Associates, Inc.
    • Xeltis BV
Product Code: MRR-034B50030374

The Vascular Graft Market is projected to grow by USD 4.13 billion at a CAGR of 7.58% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.30 billion
Estimated Year [2025] USD 2.47 billion
Forecast Year [2032] USD 4.13 billion
CAGR (%) 7.58%

A concise professional framing of the clinical, technological, and commercial imperatives shaping the next era of vascular graft utilization and strategy

The vascular graft landscape is at a pivotal inflection point driven by converging clinical demand, material innovations, and evolving care delivery models. Vascular grafts, which restore or replace compromised blood vessels, intersect disciplines ranging from cardiovascular surgery to peripheral vascular interventions, and their relevance continues to expand as demographic shifts increase the prevalence of vascular disease. Advances in biomaterials and manufacturing have broadened options for clinicians, while improvements in perioperative care and imaging are reshaping procedural decision-making. Consequently, healthcare providers and procurement teams must reconcile clinical performance needs with operational constraints and reimbursement dynamics.

Against this backdrop, stakeholders require a clear, clinically grounded synthesis of product attributes, use-case differentiation, regulatory pathways, and distribution considerations. This introduction frames the subsequent analysis by establishing the clinical imperatives that drive graft selection, the technological levers that create differentiation, and the commercial mechanisms that influence adoption. By linking clinical utility to strategic choices, the section sets the stage for pragmatic decision-making across product development, supply chain optimization, and clinical adoption pathways. Transitioning from foundational understanding to strategic insight, the remainder of the executive summary examines structural changes, tariff implications, segmentation idiosyncrasies, regional dynamics, competitive positioning, recommended actions, research approach, and concluding imperatives.

How clinical practice evolution, materials innovation, and distribution modernization are restructuring competitive dynamics across the vascular graft ecosystem

The vascular graft ecosystem is experiencing transformative shifts driven by material science breakthroughs, shifting clinical protocols, and a reorientation of care delivery away from centralized hospital settings toward outpatient and ambulatory modalities. Innovations in biologics and synthetic polymers are enabling grafts that better mimic native hemodynamics and reduce thrombogenicity, while hybrid constructs and surface modifications are expanding the range of viable indications. At the same time, procedural pathways are evolving: minimally invasive approaches and hybrid operating suites are becoming more prevalent, altering the perioperative workflow and device compatibility requirements.

Concurrently, regulatory scrutiny and quality standards have intensified, prompting manufacturers to invest in robust evidence generation and post-market surveillance. Supply chain resilience and distribution agility have come into sharper focus, with stakeholders prioritizing multiple sourcing strategies and deeper distributor partnerships. These shifts are compounded by an accelerated digital adoption in procurement and clinician education, which supports faster dissemination of clinical data and device use protocols. Taken together, these dynamics create both disruption and opportunity; companies that align R&D priorities with changing clinician workflows and invest in rigorous clinical validation will be positioned to capture expanding clinical use cases and sustain longer-term adoption.

Assessing how evolving trade measures and tariff dynamics are reshaping sourcing decisions, supply chain resiliency, and procurement strategies for vascular graft stakeholders

Policy and trade instruments have introduced a new variable into supply chain calculus and procurement planning, as tariffs and related trade measures influence sourcing strategies and cost structures. Tariff-driven cost pressures have prompted manufacturers and health systems to reassess supplier footprints, consider nearshoring or reshoring options, and revisit long-term contracts to mitigate exposure. These responses are not solely commercial; they also affect clinical operations, as procurement timelines and inventory policies are adjusted to ensure continuity of care and to preserve access to preferred graft types.

Healthcare organizations are increasingly conducting total-cost-of-ownership analyses that incorporate tariff impacts, logistics volatility, and potential delays. In parallel, manufacturers are evaluating tariff mitigation approaches such as tariff engineering, alternative routing, localization of key components, and strategic partnerships with regional contract manufacturers. The net effect is a realignment of distribution networks and a heightened emphasis on multi-tiered contingency planning. As stakeholders adapt, collaboration between clinical leaders, procurement teams, and supply chain experts becomes essential to balance cost containment with clinical performance imperatives and to ensure that patient care pathways remain uninterrupted despite geopolitical and policy fluctuations.

A nuanced segmentation framework linking product materials, sizing, indications, end-user environments, and distribution channels to clinical adoption and commercial strategy

Segmentation provides the analytical scaffolding to understand differential adoption patterns and clinical fit across product categories, sizes, indications, end users, and distribution channels. When viewed through the lens of product type, distinctions between Biological Vascular Grafts and Synthetic Vascular Grafts become salient: biological options encompassing allografts, autografts, and xenografts bring inherent biocompatibility advantages but often require specialized handling and donor-sourcing considerations, whereas synthetic offerings such as polyester, polytetrafluoroethylene, and polyurethane deliver manufacturing consistency and scalable supply chains but must address thrombogenicity and long-term patency concerns. These material and handling differences directly influence clinician preference and inventory management.

Blood vessel diameter segmentation into large and small categories further refines clinical decision-making because sizing constraints and flow dynamics alter graft selection criteria and surgical technique. Indication-focused segmentation underscores that procedural contexts-ranging from aortoiliac bypass surgery and cerebral artery bypass surgery to coronary artery bypass surgery, lower extremity bypass, peripheral artery bypass, and renal artery bypass-impose unique hemodynamic and anatomic demands that affect device design and evidence requirements. End-user distinctions between ambulatory surgical centers and hospitals and clinics highlight divergent procedural volumes, staffing models, and procurement capabilities, which in turn influence preferred product portfolios. Finally, distribution channel segmentation across offline and online pathways shapes how products reach clinicians and purchasers; offline channels continue to support hands-on training and logistics for complex devices, while online channels accelerate information access and volume-based procurement. By integrating these segmentation dimensions, stakeholders can more precisely target development, clinical evidence generation, and commercial strategies to meet differentiated clinical and operational needs.

Regional dynamics and health system nuances that determine procurement preferences, clinical adoption pathways, and distribution strategies across major global markets

Regional dynamics exert a profound influence on clinical practice patterns, regulatory expectations, and supply chain architectures across the vascular graft landscape. In the Americas, health systems exhibit a mix of advanced clinical infrastructure and complex reimbursement ecosystems that drive demands for robust long-term evidence and high-performance devices, while the presence of large independent distributors affects channel strategies and inventory practices. In Europe, Middle East & Africa, heterogeneity across national healthcare systems requires adaptable regulatory strategies and flexible pricing approaches, with some markets emphasizing portability and cost-effectiveness and others prioritizing innovation and premium-performance solutions. The Asia-Pacific region presents a dual dynamic of rapidly expanding clinical capacity in urban centers alongside cost-sensitive procurement in developing markets, creating opportunities for both premium and value-focused product offerings.

Across these regions, differences in physician training pathways, procedural volumes, and hospital versus ambulatory care balance shape adoption curves for specific graft types and technologies. Supply chain implications also vary: proximity to manufacturing hubs, regional trade agreements, and logistics infrastructure affect lead times and inventory management. Consequently, companies pursuing geographic expansion must tailor their clinical engagement, regulatory submissions, and distribution partnerships to regional idiosyncrasies while maintaining consistent quality and evidence standards. Strategic regional alignment, informed by local clinical champions and operational partners, will be critical to unlocking sustained adoption across disparate healthcare systems.

Competitive positioning essentials emphasizing clinical evidence, manufacturing strength, strategic partnerships, and commercialization models that influence leadership in the vascular graft sector

Competitive positioning in the vascular graft domain rests on a combination of clinical evidence, material innovation, manufacturing reliability, regulatory compliance, and channel strength. Established manufacturers with integrated manufacturing and post-market surveillance capabilities leverage their track record to engage large hospital systems and academic centers, often coupling product portfolios with training and clinical support programs to drive preference. Emerging players and startups are differentiating through novel biomaterials, surface-engineering approaches, and targeted indications, seeking to demonstrate clinical superiority or differentiated ease of use in focused clinical scenarios.

Partnerships between device developers and contract manufacturers or specialty coating suppliers are increasingly common as companies accelerate time-to-clinic while controlling capital intensity. Distribution strategies range from deep direct-sales relationships in high-touch hospital environments to hybrid models that employ third-party distributors and e-commerce platforms for routine replenishment. In addition, strategic alliances with clinical research networks and registry platforms enable firms to generate high-quality real-world evidence that supports formulary inclusion and clinician adoption. Ultimately, companies that effectively align R&D priorities with scalable manufacturing and a differentiated commercial approach will be better positioned to navigate reimbursement pressures and clinician expectations while protecting long-term revenue streams.

Actionable strategic priorities for manufacturers and healthcare leaders to strengthen clinical evidence, supply resilience, and tailored commercialization for vascular grafts

Industry leaders must pursue a coordinated set of actions that address clinical, operational, and commercial dimensions to capture long-term value. Prioritizing rigorous clinical validation for targeted indications will strengthen reimbursement discussions and clinician confidence, especially when evidence generation is coupled with registries and post-market surveillance that demonstrate real-world performance. Simultaneously, investing in material science initiatives-whether in biologic scaffolds, hybrid constructs, or surface-modification technologies-can create meaningful differentiation by improving patency and reducing complication rates.

Operationally, diversifying manufacturing footprints and developing contingency sourcing plans will mitigate tariff and logistics risks, while partnerships with regional manufacturers can accelerate market entry and lower lead times. Commercially, tailored go-to-market strategies that recognize differences between ambulatory surgical centers and hospitals and clinics will improve uptake; high-touch education and hands-on training are critical in complex procedures, whereas streamlined procurement and repeatable logistics support scale in high-volume contexts. Finally, embracing digital channels for clinician engagement and leveraging online distribution for routine replenishment can complement traditional sales models. By implementing these integrated recommendations, organizations can enhance resilience, foster clinician trust, and align product offerings with evolving care delivery norms.

A concise description of the evidence sources, stakeholder consultations, and analytical approaches used to synthesize clinical, commercial, and supply chain insights

This research synthesis is grounded in a systematic review of peer-reviewed clinical literature, regulatory documentation, patent landscapes, publicly available clinical registries, and stakeholder interviews with clinicians, supply chain leaders, and commercial experts. Primary qualitative inputs were obtained through structured consultations to validate clinical preferences, device handling considerations, and procurement dynamics. Secondary sources provided context on material science trends, device approvals, and procedural guidelines, enabling triangulation of insights across evidence streams.

Analytical approaches included comparative evaluation of device attributes against clinical requirements for different indications and diameters, assessment of distribution channel efficacy, and scenario analysis to examine the implications of tariff-induced supply chain adjustments. Care was taken to corroborate assertions with multiple independent sources and to distinguish established clinical consensus from emerging hypotheses. Throughout, emphasis was placed on actionable insight rather than raw enumeration of datasets, ensuring that findings are directly relevant to product strategy, clinical engagement, and procurement planning. Where appropriate, limitations and areas requiring further primary data collection are noted to guide follow-up research and evidence generation efforts.

A strategic synthesis highlighting the convergence of clinical validation, material innovation, and supply resilience as the foundation for sustained adoption of vascular graft technologies

In sum, the vascular graft landscape is maturing along multiple dimensions: clinical evidence expectations are rising, material and manufacturing innovations are expanding therapeutic possibilities, and supply chain and distribution strategies are being recalibrated in response to policy and logistical factors. These concurrent developments create a complex environment in which clinical performance, operational resilience, and regulatory alignment each play decisive roles. For stakeholders, success will require integrated strategies that marry rigorous evidence generation with manufacturing adaptability and customized commercial execution.

Moving forward, the most durable advantage will accrue to organizations that can rapidly translate scientific advances into validated clinical benefits, maintain flexible and redundant supply networks, and engage clinicians with targeted educational and operational support. By doing so, stakeholders can ensure that the promise of new graft technologies is realized in improved patient outcomes and sustainable clinical adoption pathways. The concluding call to action is clear: align innovation with pragmatic implementation to capture emerging opportunities while safeguarding continuity of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Advancements in bioengineered small-diameter vascular grafts with endothelialization for coronary applications
  • 5.2. Increasing adoption of resorbable polymer composite grafts in pediatric vascular reconstruction procedures
  • 5.3. Growing utilization of heparin-coated expanded polytetrafluoroethylene grafts in diabetic limb salvage surgeries
  • 5.4. Emergence of 3D-printed patient-specific vascular grafts to optimize hemodynamic performance in aneurysm repair
  • 5.5. Rising investments in tissue-engineered graft technologies integrating stem cell seeding for improved long-term patency rates
  • 5.6. Impact of evolving reimbursement policies and value-based care models on vascular graft adoption in emerging markets

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vascular Graft Market, by Product Type

  • 8.1. Biological Vascular Grafts
    • 8.1.1. Allografts
    • 8.1.2. Autografts
    • 8.1.3. Xenografts
  • 8.2. Synthetic Vascular Grafts
    • 8.2.1. Polyester
    • 8.2.2. Polytetrafluoroethylene
    • 8.2.3. Polyurethane

9. Vascular Graft Market, by Blood Vessel Diameter

  • 9.1. Large
  • 9.2. Small

10. Vascular Graft Market, by Indication

  • 10.1. Aortoiliac Bypass Surgery
  • 10.2. Cerebral Artery Bypass Surgery
  • 10.3. Coronary Artery Bypass Surgery
  • 10.4. Lower Extremity Bypass Surgery
  • 10.5. Peripheral Artery Bypass Surgery
  • 10.6. Renal Artery Bypass Surgery

11. Vascular Graft Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals & Clinics

12. Vascular Graft Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Vascular Graft Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Vascular Graft Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Vascular Graft Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Affluent Medical
    • 16.3.3. B. Braun Melsungen AG
    • 16.3.4. Becton, Dickinson and Company
    • 16.3.5. BIOVIC Sdn. Bhd.
    • 16.3.6. Boston Scientific Corporation
    • 16.3.7. Cardinal Health Inc.
    • 16.3.8. Cook Medical, Inc.
    • 16.3.9. Corcym S.r.l.
    • 16.3.10. CryoLife, Inc.
    • 16.3.11. Endologix Inc.
    • 16.3.12. Getinge AB
    • 16.3.13. Heart Medical Europe B.V.
    • 16.3.14. Japan Lifeline Co., Ltd.
    • 16.3.15. Lemaitre Vascular, Inc.
    • 16.3.16. Medtronic PLC
    • 16.3.17. Merit Medical Systems, Inc.
    • 16.3.18. Perouse Medical SAS by Vygon SAS
    • 16.3.19. Rua Life Sciences PLC
    • 16.3.20. Shanghai Suokang Medical Implants Co. Ltd.
    • 16.3.21. Terumo Corporation
    • 16.3.22. Vascular Graft Solutions Ltd.
    • 16.3.23. VUP Medical
    • 16.3.24. W. L. Gore & Associates, Inc.
    • 16.3.25. Xeltis B.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VASCULAR GRAFT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VASCULAR GRAFT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ALLOGRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ALLOGRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ALLOGRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ALLOGRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AUTOGRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AUTOGRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AUTOGRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AUTOGRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AUTOGRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AUTOGRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR GRAFT MARKET SIZE, BY XENOGRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR GRAFT MARKET SIZE, BY XENOGRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VASCULAR GRAFT MARKET SIZE, BY XENOGRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VASCULAR GRAFT MARKET SIZE, BY XENOGRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VASCULAR GRAFT MARKET SIZE, BY XENOGRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VASCULAR GRAFT MARKET SIZE, BY XENOGRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LARGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LARGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LARGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LARGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LARGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LARGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SMALL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SMALL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SMALL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SMALL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SMALL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SMALL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AORTOILIAC BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AORTOILIAC BYPASS SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AORTOILIAC BYPASS SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AORTOILIAC BYPASS SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AORTOILIAC BYPASS SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AORTOILIAC BYPASS SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CEREBRAL ARTERY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CEREBRAL ARTERY BYPASS SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CEREBRAL ARTERY BYPASS SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CEREBRAL ARTERY BYPASS SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CEREBRAL ARTERY BYPASS SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CEREBRAL ARTERY BYPASS SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LOWER EXTREMITY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LOWER EXTREMITY BYPASS SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LOWER EXTREMITY BYPASS SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LOWER EXTREMITY BYPASS SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LOWER EXTREMITY BYPASS SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LOWER EXTREMITY BYPASS SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL ARTERY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL ARTERY BYPASS SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL ARTERY BYPASS SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL ARTERY BYPASS SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL ARTERY BYPASS SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL ARTERY BYPASS SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RENAL ARTERY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RENAL ARTERY BYPASS SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RENAL ARTERY BYPASS SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RENAL ARTERY BYPASS SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RENAL ARTERY BYPASS SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RENAL ARTERY BYPASS SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VASCULAR GRAFT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VASCULAR GRAFT MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VASCULAR GRAFT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VASCULAR GRAFT MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VASCULAR GRAFT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VASCULAR GRAFT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS VASCULAR GRAFT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS VASCULAR GRAFT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 226. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL VASCULAR GRAFT MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. GCC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GCC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GCC VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. GCC VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. GCC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 292. GCC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 293. GCC VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 294. GCC VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 295. GCC VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 296. GCC VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 297. GCC VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 298. GCC VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 299. GCC VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. GCC VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. GCC VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. GCC VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025-2032 (USD MILLION)
  • TABLE 329. BRICS VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 330. BRICS VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 331. BRICS VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. BRICS VASCULAR GRAFT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. BRICS VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 334. BRICS VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 335. G7 VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 336. G7 VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025-20